Dermapharm Holding SE buy DirectorDealer
Start price
13.10.22
/
50%
€39.30
Target price
13.10.23
-
Performance (%)
-0.71%
End price
14.10.23
€39.02
Summary
This prediction ended on 14.10.23 with a price of €39.02. During the runtime of the prediction for Dermapharm Holding SE the price only changed by -0.71%. DirectorDealer has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -1.022% | -1.022% | -2.760% | 4.673% |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% | 68.731% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% | 113.533% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% | 50.934% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% | 68.205% |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Themis Beteiligungs-Aktiengesellschaft (in enger Beziehung)
- Handelstag: 12.10.2022
- Volumen: 55825000 €
- Meldende_r: Themis Beteiligungs-Aktiengesellschaft
In the thread Trading Dermapharm Holding SE
Die von DirectorDealer gewählte maximale Laufzeit wurde überschritten